Legal status · United Kingdom
Is Nicotinamide Riboside legal in the United Kingdom?
Nicotinamide Riboside can be sold in the United Kingdom as a supplement or cosmetic ingredient, classified as "Sold as a supplement". That is not drug approval: MHRA has not evaluated any health claim, and injectable or "research use only" versions fall outside supplement rules, so that label does not make human use lawful. Human evidence: Moderate.
Nicotinamide Riboside in the United Kingdom at a glance
| Classification | Sold as a supplement |
|---|---|
| MHRA approval status | Not a MHRA drug approval; sold as a supplement or cosmetic |
| Evidence level | Moderate (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Nicotinamide Riboside profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
Nicotinamide Riboside can be sold in the United Kingdom as a supplement, food or cosmetic ingredient under the classification above, without drug approval.
- 02
Supplement status means MHRA has not evaluated any health claim; manufacturers are responsible for safety and labeling, and quality varies by product.
- 03
Injectable or "research use only" versions are not supplements. That label does not make human use lawful, and injectables fall under medicines rules.
What Nicotinamide Riboside is
A well-studied vitamin B3 form and NAD+ precursor that reliably raises NAD+ levels in humans, widely used in longevity supplement stacks.
Nicotinamide riboside is a form of vitamin B3 that the body converts into NAD+, the coenzyme central to energy metabolism and cellular repair. Human trials show it safely and reliably raises NAD+ levels, and it is one of the most studied NAD+ precursors, sold as a supplement (for example Niagen).
Mechanism: Converts to NAD+ through the salvage pathway, restoring NAD+ that declines with age and supporting mitochondrial and repair enzymes.
Regulatory history: Sold as a supplement; not an approved drug
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Nicotinamide Riboside at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Nicotinamide Riboside in other countries
United States
Supplement or cosmeticSold as a dietary supplement
Is Nicotinamide Riboside legal in the United States?Australia
Supplement or cosmeticAvailable as a supplement / complementary medicine
Is Nicotinamide Riboside legal in Australia?Canada
Supplement or cosmeticSold as a supplement
Is Nicotinamide Riboside legal in Canada?Frequently asked questions
Is Nicotinamide Riboside legal in the United Kingdom?
Nicotinamide Riboside can be sold in the United Kingdom as a supplement or cosmetic ingredient, classified as "Sold as a supplement". That is not drug approval: MHRA has not evaluated any health claim, and injectable or "research use only" versions fall outside supplement rules, so that label does not make human use lawful. Human evidence: Moderate.
Can I buy Nicotinamide Riboside in the United Kingdom?
Yes, in supplement or cosmetic form. In the United Kingdom Nicotinamide Riboside is classified as "Sold as a supplement", so oral, topical or cosmetic products can be sold under supplement rules. Injectable versions and products labeled "research use only" are not supplements and are not approved for human use.
Is Nicotinamide Riboside MHRA approved?
No. In the United Kingdom Nicotinamide Riboside is classified as "Sold as a supplement", which is not a MHRA marketing approval. For comparison, the US FDA status is: Sold as a supplement; not an approved drug. Evidence level: Moderate.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Nicotinamide Riboside live on its compound profile.
Nicotinamide Riboside profileThis page is general information about the regulatory status of Nicotinamide Riboside in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.